Equitable Access to High-Cost Pharmaceuticals

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Business & Finance, Industries & Professions, Industries
Cover of the book Equitable Access to High-Cost Pharmaceuticals by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128119624
Publisher: Elsevier Science Publication: February 27, 2018
Imprint: Academic Press Language: English
Author:
ISBN: 9780128119624
Publisher: Elsevier Science
Publication: February 27, 2018
Imprint: Academic Press
Language: English

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines.

  • Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs
  • Incorporates existing guidelines and recommendations by international organizations
  • Compares and contrasts how different countries fund and police high-cost drug access
  • Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing
  • Reviews novel pharmaceuticals of current research interest
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines.

More books from Elsevier Science

Cover of the book Enzyme Nanoarchitectures: Enzymes Armored with Graphene by
Cover of the book Advances in Immunology by
Cover of the book Gaseous Hydrogen Embrittlement of Materials in Energy Technologies by
Cover of the book Antiphospholipid Syndrome in Systemic Autoimmune Diseases by
Cover of the book Generalized Continuum Mechanics and Engineering Applications by
Cover of the book Roots of Brazilian Relative Economic Backwardness by
Cover of the book Industrial Control Technology by
Cover of the book Digital Systems Design with FPGAs and CPLDs by
Cover of the book Development of Responsiveness to Steroid Hormones by
Cover of the book The Welding of Aluminium and Its Alloys by
Cover of the book Varicose Veins and Related Disorders by
Cover of the book Advances in Agronomy by
Cover of the book Characterization of Porous Solids VII by
Cover of the book Data Mining by
Cover of the book Process Systems Engineering for Pharmaceutical Manufacturing by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy